Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
immune system diseases | D007154 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
graft vs host disease | — | D006086 | D89.81 |
psoriasis | EFO_0000676 | D011565 | L40 |
Code | Description |
---|---|
J7518 | Mycophenolic acid, oral, 180 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney transplantation | D016030 | — | — | 12 | 37 | 41 | 83 | 15 | 180 |
Leukemia | D007938 | — | C95 | 20 | 65 | 3 | 1 | 10 | 89 |
Graft vs host disease | D006086 | — | D89.81 | 13 | 34 | 8 | 3 | 6 | 55 |
Lupus nephritis | D008181 | EFO_0005761 | — | 1 | 18 | 16 | 9 | 11 | 54 |
Liver transplantation | D016031 | EFO_0010682 | — | 2 | 9 | 11 | 15 | 5 | 40 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 8 | 10 | 3 | 13 | 7 | 34 |
Immunosuppression therapy | D007165 | — | — | 2 | 2 | 2 | 12 | 11 | 29 |
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 5 | 11 | 9 | 5 | 2 | 28 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 5 | 4 | 5 | 10 | 5 | 26 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | 10 | 1 | 1 | 8 | 20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 45 | 111 | 5 | — | 15 | 157 |
Myeloid leukemia acute | D015470 | — | C92.0 | 29 | 78 | 12 | — | 9 | 116 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 22 | 60 | 7 | — | 8 | 89 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 17 | 58 | 4 | — | 8 | 78 |
Lymphoma | D008223 | — | C85.9 | 15 | 52 | 2 | — | 9 | 71 |
Multiple myeloma | D009101 | — | C90.0 | 16 | 46 | 4 | — | 8 | 67 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 12 | 51 | 6 | — | 5 | 67 |
Hodgkin disease | D006689 | — | C81 | 15 | 48 | 5 | — | 7 | 67 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 10 | 52 | 4 | — | 6 | 66 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 5 | 28 | 3 | — | 4 | 36 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Plasma cell neoplasms | D054219 | — | — | 7 | 23 | — | — | 4 | 31 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 13 | 20 | — | — | 2 | 29 |
Aplastic anemia | D000741 | HP_0001915 | D61.9 | 3 | 16 | — | — | 2 | 20 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 15 | — | — | 4 | 20 |
Anemia | D000740 | HP_0001903 | D64.9 | 8 | 13 | — | — | — | 18 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 8 | 10 | — | — | 2 | 17 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | 3 | 12 | — | — | 3 | 16 |
Lymphomatoid granulomatosis | D008230 | — | C83.8 | 3 | 12 | — | — | 3 | 16 |
Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 4 | 11 | — | — | 2 | 15 |
Extranodal nk-t-cell lymphoma | D054391 | — | C86.0 | 3 | 11 | — | — | 3 | 15 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 16 | — | — | — | 2 | 18 |
Glioblastoma | D005909 | EFO_0000515 | — | 2 | — | — | — | — | 2 |
Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | 1 | — | — | — | 1 | 2 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | — | 1 |
Germ cell and embryonal neoplasms | D009373 | — | — | 1 | — | — | — | — | 1 |
Medulloblastoma | D008527 | — | — | 1 | — | — | — | — | 1 |
Ependymoma | D004806 | — | — | 1 | — | — | — | — | 1 |
Choroid plexus neoplasms | D016545 | EFO_0007206 | — | 1 | — | — | — | — | 1 |
Primitive neuroectodermal tumors | D018242 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Islets of langerhans transplantation | D016381 | — | — | — | — | — | — | 2 | 2 |
Heart disease risk factors | D000082742 | — | — | — | — | — | — | 1 | 1 |
Bone diseases | D001847 | — | M89.9 | — | — | — | — | 1 | 1 |
Death | D003643 | PATO_0001422 | — | — | — | — | — | 1 | 1 |
Antibody formation | D000917 | — | — | — | — | — | — | 1 | 1 |
Choroidal neovascularization | D020256 | — | — | — | — | — | — | 1 | 1 |
Scleritis | D015423 | HP_0100534 | H15.0 | — | — | — | — | 1 | 1 |
Lysosomal storage diseases | D016464 | — | — | — | — | — | — | 1 | 1 |
Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 1 | 1 |
Proteinuria | D011507 | HP_0000093 | R80 | — | — | — | — | 1 | 1 |
Drug common name | Mycophenolic acid |
INN | mycophenolic acid |
Description | Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans. It is functionally related to a hex-4-enoic acid. It is a conjugate acid of a mycophenolate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2 |
PDB | — |
CAS-ID | 24280-93-1 |
RxCUI | — |
ChEMBL ID | CHEMBL866 |
ChEBI ID | 168396 |
PubChem CID | 446541 |
DrugBank | DB01024 |
UNII ID | HU9DX48N0T (ChemIDplus, GSRS) |